March 23 (Reuters) - San Francisco Federal Reserve Bank President Mary Daly on Monday said that unless the Iran conflict resolves quickly and the Fed can simply "look through" a temporary ...
A college project during her senior year would change everything for Staci Sawyer. At the time, Sawyer was living in Las Vegas, attending school while awaiting the birth of her child. Looking for ...
Speaker Mike Johnson previewed a floor strategy Wednesday that would leave little room for Republican defections as he pushes to renew a powerful surveillance authority, with chamber leadership ...
Within the Senate’s housing bill lie the terms of an unusual debate: Who gets to own — and live in — single-family homes? By Conor Dougherty and Ronda Kaysen Conor Dougherty attended the build-to-rent ...
Apple will spend $400 million through 2030 on new programs with Bosch, Cirrus Logic, TDK, and Qnity Electronics to manufacture essential materials and components in the U.S. The expansion builds on ...
HOUSTON — It’s perfectly normal to fear the AI apocalypse: the loss of jobs, the destruction of natural resources, the bastardization of human creativity for corporate profit, whether or not it will ...
Hosted on MSN
Fed's Daly: No single most-likely path for rates
March 23 (Reuters) - San Francisco Federal Reserve Bank President Mary Daly on Monday said that unless the Iran conflict resolves quickly and the Fed can simply "look through" a temporary increase in ...
Unmanned Surface Vessel Division 12 and 13 conduct unit-level training in San Diego Bay in 2025. (Lt.j.g. Cody Davidson/Navy) The U.S. Navy announced a new chapter of unmanned surface vessel ...
Dawn Butler worked in information technology and cybersecurity roles for two decades. But she was laid off from a major bank in 2024, almost exactly 10 years after her first layoff. The timing was not ...
The program is run by the Florida Department of Emergency Management and provides assistance to homeowners who are seeking to elevate their home above the flood plain. Federal funds of $400 million ...
Innovent Biologics’ eye disease prospect has matched Bayer and Regeneron’s Eylea in a phase 3 study, teeing up filings for Chinese approval of a molecule that could reduce maintenance dose frequency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results